Health officials have said a new drug for skin cancer patients should be made available for widespread use on the NHS A new drug for skin cancer patients should be made available for widespread use on the NHS, health officials have said. The drug dabrafenib can have a "rapid positive effect" on patients with a certain type of melanoma, the National Institute for Health and Care Excellence said.